| dc.contributor.author | O'DRISCOLL, LORRAINE | en |
| dc.date.accessioned | 2017-01-19T11:10:22Z | |
| dc.date.available | 2017-01-19T11:10:22Z | |
| dc.date.issued | 2009 | en |
| dc.date.submitted | 2009 | en |
| dc.identifier.citation | Collins DM, Crown J, O'Donovan N, Devery A, O'Sullivan F, O'Driscoll L, Clynes M, O'Connor R., Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines., Invest New Drugs, 28, 4, 2009, 433 - 444 | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.format.extent | 433 | en |
| dc.format.extent | 444 | en |
| dc.relation.ispartofseries | Invest New Drugs | en |
| dc.relation.ispartofseries | 28 | en |
| dc.relation.ispartofseries | 4 | en |
| dc.rights | Y | en |
| dc.title | Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines. | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/lodrisc | en |
| dc.identifier.rssinternalid | 59194 | en |
| dc.identifier.doi | http://dx.doi.org/10.1007/s10637-009-9266-0 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.rssuri | http://www.ncbi.nlm.nih.gov/pubmed/19499189 | en |
| dc.identifier.orcid_id | 0000-0002-9860-8262 | en |
| dc.identifier.uri | http://hdl.handle.net/2262/79025 | |
